Raloxifene, a SERM targets PD-L1: an in-silico study.

Chopra, Chirag; Yodun, Tenzen; Singh, Harpreet; Singh, Bhupender; Singh, Shashank K; Goutam, Umesh.

Chopra C; School of Bioengineering and Biosciences, Lovely Professional University Phagwara, Punjab, India.
Yodun T; Cancer Pharmacology Division, Indian Institute of Integrative Medicine (CSIR) Jammu, J&K, India.
Singh H; Department of Bioinformatics, Hans Raj Mahila Maha Vidyalaya Jalandhar, Punjab, India.
Singh B; School of Bioengineering and Biosciences, Lovely Professional University Phagwara, Punjab, India.
Singh SK; Cancer Pharmacology Division, Indian Institute of Integrative Medicine (CSIR) Jammu, J&K, India.
Goutam U; School of Bioengineering and Biosciences, Lovely Professional University Phagwara, Punjab, India.

Am J Transl Res ; 15(8): 5206-5215, 2023.

Article en En | MEDLINE | ID: mdl-37692949